Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia
Results
Phase 3
This trial compared a chemotherapy drug called azacitidine with the usual treatment for older people with acute myeloid leukaemia (AML).
Recruitment start: 19 October 2010
Recruitment end: 16 October 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Michael Potter
Celgene Ltd
Last reviewed: 15 Oct 2012
CRUK internal database number: 7835
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
